Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Amy Puenpatom"'
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review
Autor:
Julia Richmond DiBello, Valerie T. Raziano, Xinyue Liu, Amy Puenpatom, Kathryn Peebles, Nazleen F. Khan, Deanna D. Hill
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1177-1198 (2024)
Abstract Introduction Molnupiravir (MOV) is an oral antiviral for the treatment of individuals with mild-to-moderate COVID-19 and at high risk of progression to severe disease. Our objective was to conduct a systematic literature review (SLR) of evid
Externí odkaz:
https://doaj.org/article/058d82970fcd4eae99d44751766d80ec
Autor:
Nicole S Erler, Robert J de Knegt, Jordan J Feld, Bettina E Hansen, Harry L A Janssen, Adriaan J van der Meer, Christoph Welsch, Stefan Zeuzem, Amy Puenpatom, Thomas Vanwolleghem, Robert A de Man, Lisette A P Krassenburg, Raoel Maan, Stijn van Hees, Orlando Cerrhoci, Johannes Vermehren
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Background and aims Historical paired liver biopsy studies are likely to underestimate current progression of disease in patients with chronic hepatitis C virus (HCV) infection. We aimed to assess liver disease progression according to the non-invasi
Externí odkaz:
https://doaj.org/article/20684bd7459a42a999c55f58c9c6cca6
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 2, Pp 355-365 (2020)
Abstract Introduction Real-world treatment of hepatitis C virus (HCV) infection is complicated by many factors that are controlled for in the rigorous clinical trial setting. The aim of the present study was to assess the efficacy of elbasvir/grazopr
Externí odkaz:
https://doaj.org/article/cd3b816f0ad94caf9c8bdafba367de85
Autor:
Sami Hoque, Christopher M Black, Amy Puenpatom, Simona Boccaletti, Chloe Green, Jenna Roberts, Ivana Rajkovic, Gary Milligan
Publikováno v:
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020)
Objective To examine real-world treatment persistence, colectomy-free survival and treatment switching patterns in UK patients with ulcerative colitis (UC) prescribed golimumab or adalimumab.Design This was a retrospective chart review study in adult
Externí odkaz:
https://doaj.org/article/05fdd8a6dc56498e8fe42755035d5d3c
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0218759 (2019)
BackgroundData on initiation and utilization of direct-acting antiviral therapies for hepatitis C virus infection in the United States are limited. This study evaluated treatment initiation, time to treatment, and real-world effectiveness of direct-a
Externí odkaz:
https://doaj.org/article/23fd05918b9e4c2db6b52b777afce5cd
Autor:
Ebuwa Igho-Osagie, Amy Puenpatom, Marissa Grifasi Williams, Yan Song, Denise Yi, Jessie Wang, Richard Berman, Miley Gu, Chujun He
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:509-518
Autor:
Olav Dalgard, Alain H. Litwin, Oren Shibolet, Jason Grebely, Ronald Nahass, Frederick L. Altice, Brian Conway, Edward J. Gane, Anne F. Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M. Kelly, Barbara A. Haber, Heather Platt, Amy Puenpatom
Publikováno v:
Journal of Addictive Diseases. :1-12
Background In people with chronic hepatitis C virus (HCV) infection, viral eradication is associated with improved health-related quality of life (HRQOL). Objective To assess changes in HRQOL among participants receiving opioid agonist therapy underg
Autor:
Ebuwa Igho-Osagie, Kaylen Brzozowski, Harry Jin, Jeffrey Brown, Marissa Grifasi Williams, Amy Puenpatom
Publikováno v:
Clinical Therapeutics.
Publikováno v:
The American Journal of Drug and Alcohol Abuse. 48:445-453
Autor:
Salvatore D’Angelo, Enrico Tirri, Angela Maria Giardino, Marco Mattucci-Cerinic, Lorenzo Dagna, Leonardo Santo, Francesco Ciccia, Bruno Frediani, Marcello Govoni, Francesca Bobbio Pallavicini, Rosa Daniela Grembiale, Andrea Delle Sedie, Rita Mulè, Francesco Paolo Cantatore, Rosario Foti, Elisa Gremese, Paola Conigliaro, Fausto Salaffi, Ombretta Viapiana, Alberto Cauli, Roberto Giacomelli, Luisa Arcarese, Giuliana Guggino, Romualdo Russo, Amy Puenpatom, Domenico Capocotta, Francesca Nacci, Maria Grazia Anelli, Valentina Picerno, Corrado Binetti, Florenzo Iannone
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 14; Pages: 4178
In this prospective observational study, data were collected from 34 rheumatology clinics in Italy in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) who started golimumab (GLM) as a second anti-